- 現金殖利率: 5.0%、總殖利率: 5.0%、5年平均現金配發率: 84.45%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 7.98 | -11.63 | 7.00 | 0.0 | 0.00 | 0 | 87.72 | 13.16 | 0.00 | 0 | 87.72 | 13.16 |
| 2022 (9) | 9.03 | 4.15 | 7.00 | 0.0 | 0.00 | 0 | 77.52 | -3.99 | 0.00 | 0 | 77.52 | -3.99 |
| 2021 (8) | 8.67 | 8.1 | 7.00 | 3.4 | 0.00 | 0 | 80.74 | -4.35 | 0.00 | 0 | 80.74 | -4.35 |
| 2020 (7) | 8.02 | 22.82 | 6.77 | 12.83 | 0.00 | 0 | 84.41 | -8.13 | 0.00 | 0 | 84.41 | -8.13 |
| 2019 (6) | 6.53 | -6.04 | 6.00 | 0.0 | 0.00 | 0 | 91.88 | 6.43 | 0.00 | 0 | 91.88 | 6.43 |
| 2018 (5) | 6.95 | -3.07 | 6.00 | 0.0 | 0.00 | 0 | 86.33 | 3.17 | 0.00 | 0 | 86.33 | 3.17 |
| 2017 (4) | 7.17 | 21.11 | 6.00 | 20.0 | 0.00 | 0 | 83.68 | -0.92 | 0.00 | 0 | 83.68 | -0.92 |
| 2016 (3) | 5.92 | -4.36 | 5.00 | 0.0 | 0.00 | 0 | 84.46 | 4.56 | 0.00 | 0 | 84.46 | 4.56 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 23Q4 (20) | 1.90 | -3.55 | -10.38 | 1.74 | -10.77 | -25.32 | 8.01 | 30.24 | -11.59 |
| 23Q3 (19) | 1.97 | -5.29 | 19.39 | 1.95 | 0.0 | 21.87 | 6.15 | 46.78 | -11.51 |
| 23Q2 (18) | 2.08 | -1.42 | -30.9 | 1.95 | 7.73 | -26.42 | 4.19 | 98.58 | -20.94 |
| 23Q1 (17) | 2.11 | -0.47 | -7.86 | 1.81 | -22.32 | -12.56 | 2.11 | -76.71 | -7.86 |
| 22Q4 (16) | 2.12 | 28.48 | -9.4 | 2.33 | 45.62 | 12.56 | 9.06 | 30.36 | 0.78 |
| 22Q3 (15) | 1.65 | -45.18 | -22.9 | 1.60 | -39.62 | -17.1 | 6.95 | 31.13 | 3.42 |
| 22Q2 (14) | 3.01 | 31.44 | 24.9 | 2.65 | 28.02 | 33.84 | 5.30 | 131.44 | 15.72 |
| 22Q1 (13) | 2.29 | -2.14 | 5.53 | 2.07 | 0.0 | 23.95 | 2.29 | -74.53 | 5.53 |
| 21Q4 (12) | 2.34 | 9.35 | 6.36 | 2.07 | 7.25 | 20.35 | 8.99 | 33.78 | 3.1 |
| 21Q3 (11) | 2.14 | -11.2 | -15.08 | 1.93 | -2.53 | 1.05 | 6.72 | 46.72 | 2.13 |
| 21Q2 (10) | 2.41 | 11.06 | 7.59 | 1.98 | 18.56 | 10.61 | 4.58 | 111.06 | 12.81 |
| 21Q1 (9) | 2.17 | -1.36 | 19.89 | 1.67 | -2.91 | 10.6 | 2.17 | -75.11 | 19.89 |
| 20Q4 (8) | 2.20 | -12.7 | 9.45 | 1.72 | -9.95 | 22.86 | 8.72 | 32.52 | 26.19 |
| 20Q3 (7) | 2.52 | 12.5 | 72.6 | 1.91 | 6.7 | 64.66 | 6.58 | 62.07 | 33.74 |
| 20Q2 (6) | 2.24 | 23.76 | 34.94 | 1.79 | 18.54 | 16.99 | 4.06 | 124.31 | 17.0 |
| 20Q1 (5) | 1.81 | -9.95 | 0.0 | 1.51 | 7.86 | 7.86 | 1.81 | -73.81 | 0.0 |
| 19Q4 (4) | 2.01 | 37.67 | 0.0 | 1.40 | 20.69 | 0.0 | 6.91 | 40.45 | 0.0 |
| 19Q3 (3) | 1.46 | -12.05 | 0.0 | 1.16 | -24.18 | 0.0 | 4.92 | 41.79 | 0.0 |
| 19Q2 (2) | 1.66 | -8.29 | 0.0 | 1.53 | 9.29 | 0.0 | 3.47 | 91.71 | 0.0 |
| 19Q1 (1) | 1.81 | 0.0 | 0.0 | 1.40 | 0.0 | 0.0 | 1.81 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/3 | 3.18 | 13.89 | -8.51 | 9.65 | -0.83 | 9.65 | N/A | - | ||
| 2024/2 | 2.8 | -23.8 | -1.78 | 6.46 | 3.43 | 9.96 | N/A | - | ||
| 2024/1 | 3.67 | 5.06 | 7.8 | 3.67 | 7.8 | 10.34 | N/A | - | ||
| 2023/12 | 3.49 | 9.81 | 1.78 | 38.96 | -16.92 | 9.82 | 0.66 | - | ||
| 2023/11 | 3.18 | 0.97 | 4.2 | 35.47 | -18.4 | 9.57 | 0.67 | - | ||
| 2023/10 | 3.15 | -2.71 | 1.49 | 32.29 | -20.11 | 9.91 | 0.65 | - | ||
| 2023/9 | 3.24 | -8.16 | -7.3 | 29.14 | -21.91 | 9.84 | 0.62 | - | ||
| 2023/8 | 3.53 | 14.35 | 9.51 | 25.9 | -23.41 | 9.98 | 0.61 | - | ||
| 2023/7 | 3.08 | -8.73 | -2.95 | 22.37 | -26.88 | 9.55 | 0.64 | - | ||
| 2023/6 | 3.38 | 9.34 | -27.0 | 19.29 | -29.65 | 9.56 | 0.61 | - | ||
| 2023/5 | 3.09 | -0.24 | -68.53 | 15.91 | -30.19 | 9.66 | 0.61 | 111年同期因有新增快篩試劑銷售業務而本年度因疫情趨緩銷售減少 | ||
| 2023/4 | 3.1 | -11.03 | -2.08 | 12.83 | -1.19 | 9.42 | 0.62 | - | ||
| 2023/3 | 3.48 | 22.26 | 1.89 | 9.73 | -0.9 | 9.73 | 0.65 | - | ||
| 2023/2 | 2.85 | -16.36 | 20.12 | 6.25 | -2.4 | 9.68 | 0.66 | - | ||
| 2023/1 | 3.4 | -0.8 | -15.63 | 3.4 | -15.63 | 9.89 | 0.64 | - | ||
| 2022/12 | 3.43 | 12.42 | 6.12 | 46.9 | 27.29 | 9.59 | 0.78 | - | ||
| 2022/11 | 3.05 | -1.64 | 4.77 | 43.47 | 29.33 | 9.65 | 0.77 | - | ||
| 2022/10 | 3.1 | -11.15 | 7.83 | 40.41 | 31.66 | 9.81 | 0.76 | - | ||
| 2022/9 | 3.49 | 8.49 | 8.57 | 37.31 | 34.13 | 9.89 | 0.8 | - | ||
| 2022/8 | 3.22 | 1.34 | 6.14 | 33.82 | 37.47 | 11.02 | 0.72 | - | ||
| 2022/7 | 3.18 | -31.35 | 15.23 | 30.6 | 41.87 | 17.62 | 0.45 | - | ||
| 2022/6 | 4.63 | -52.86 | 12.49 | 27.42 | 45.78 | 17.61 | 0.4 | - | ||
| 2022/5 | 9.82 | 210.45 | 236.11 | 22.8 | 55.09 | 16.39 | 0.43 | 因新增快篩試劑銷售業務，故本月及本年累計營業額較去年同期增加 | ||
| 2022/4 | 3.16 | -7.41 | 6.82 | 12.98 | 10.21 | 8.95 | 0.78 | - | ||
| 2022/3 | 3.42 | 44.14 | 7.36 | 9.82 | 11.34 | 9.82 | 0.6 | - | ||
| 2022/2 | 2.37 | -41.26 | -12.97 | 6.4 | 13.59 | 9.64 | 0.61 | - | ||
| 2022/1 | 4.03 | 24.77 | 38.4 | 4.03 | 38.4 | 10.18 | 0.58 | - | ||
| 2021/12 | 3.23 | 11.0 | -0.32 | 36.84 | 7.34 | 9.02 | 0.8 | - | ||
| 2021/11 | 2.91 | 1.22 | 10.08 | 33.61 | 8.14 | 9.01 | 0.8 | - | ||
| 2021/10 | 2.88 | -10.54 | 6.33 | 30.69 | 7.96 | 9.13 | 0.79 | - | ||
| 2021/9 | 3.22 | 6.06 | 2.67 | 27.82 | 8.13 | 9.01 | 0.76 | - | ||
| 2021/8 | 3.03 | 10.02 | 10.06 | 24.6 | 8.89 | 9.9 | 0.69 | - | ||
| 2021/7 | 2.76 | -32.98 | -3.64 | 21.57 | 8.72 | 9.79 | 0.69 | - | ||
| 2021/6 | 4.11 | 40.82 | 31.56 | 18.81 | 10.81 | 9.99 | 0.66 | - | ||
| 2021/5 | 2.92 | -1.32 | 12.14 | 14.7 | 6.12 | 9.06 | 0.72 | - | ||
| 2021/4 | 2.96 | -6.95 | -1.19 | 11.78 | 4.73 | 8.86 | 0.74 | - | ||
| 2021/3 | 3.18 | 16.83 | 6.32 | 8.82 | 6.88 | 8.82 | 0.75 | - | ||
| 2021/2 | 2.72 | -6.58 | 8.04 | 5.64 | 7.2 | 8.88 | 0.75 | - | ||
| 2021/1 | 2.91 | -10.13 | 6.43 | 2.91 | 6.43 | 8.8 | 0.75 | - | ||
| 2020/12 | 3.24 | 22.58 | 10.76 | 34.32 | 5.9 | 8.6 | 0.72 | - | ||
| 2020/11 | 2.65 | -2.22 | 8.16 | 31.08 | 5.41 | 8.48 | 0.73 | - | ||
| 2020/10 | 2.71 | -13.62 | -0.3 | 28.43 | 5.16 | 8.59 | 0.72 | - | ||
| 2020/9 | 3.13 | 13.7 | 12.02 | 25.72 | 5.77 | 8.75 | 0.72 | - | ||
| 2020/8 | 2.76 | -3.67 | 1.27 | 22.59 | 4.96 | 8.74 | 0.72 | - | ||
| 2020/7 | 2.86 | -8.5 | 12.31 | 19.84 | 5.5 | 8.59 | 0.73 | - | ||
| 2020/6 | 3.13 | 20.04 | 8.96 | 16.98 | 4.43 | 8.73 | 0.61 | - | ||
| 2020/5 | 2.6 | -13.06 | 1.68 | 13.85 | 3.46 | 8.59 | 0.62 | - | ||
| 2020/4 | 3.0 | 0.12 | 8.43 | 11.25 | 3.88 | 8.51 | 0.63 | - | ||
| 2020/3 | 2.99 | 18.72 | 7.42 | 8.25 | 2.32 | 8.25 | 0.66 | - | ||
| 2020/2 | 2.52 | -7.97 | 24.3 | 5.26 | -0.35 | 8.19 | 0.67 | - | ||
| 2020/1 | 2.74 | -6.47 | -15.74 | 2.74 | -15.74 | 8.11 | 0.67 | - | ||
| 2019/12 | 2.93 | 19.7 | 4.69 | 32.41 | 4.7 | 8.09 | 0.7 | - | ||
| 2019/11 | 2.45 | -9.87 | -2.62 | 29.48 | 4.7 | 7.96 | 0.72 | - | ||
| 2019/10 | 2.71 | -2.95 | 4.05 | 27.03 | 5.42 | 8.23 | 0.69 | - | ||
| 2019/9 | 2.8 | 2.79 | 9.02 | 24.32 | 5.57 | 8.06 | 0.65 | - | ||
| 2019/8 | 2.72 | 6.82 | 3.38 | 21.52 | 5.14 | 8.14 | 0.65 | - | ||
| 2019/7 | 2.55 | -11.22 | 3.46 | 18.8 | 5.4 | 7.98 | 0.66 | - | ||
| 2019/6 | 2.87 | 12.01 | 2.41 | 16.26 | 5.71 | 8.19 | 0.68 | - | ||
| 2019/5 | 2.56 | -7.29 | 3.34 | 13.39 | 6.44 | 0.0 | N/A | - | ||
| 2019/4 | 2.76 | -0.81 | 15.76 | 10.83 | 7.21 | 0.0 | N/A | - |
